首页 | 本学科首页   官方微博 | 高级检索  
     

碳青霉烯类耐药与敏感鲍曼不动杆菌医院感染经济损失的差异
引用本文:王芳,孙奇玫,刘欣,姜雪锦,宋淑霞,邵方飞,宋立霞,孙吉花. 碳青霉烯类耐药与敏感鲍曼不动杆菌医院感染经济损失的差异[J]. 中国感染控制杂志, 2019, 18(9): 842-847. DOI: 10.12138/j.issn.1671-9638.20195355
作者姓名:王芳  孙奇玫  刘欣  姜雪锦  宋淑霞  邵方飞  宋立霞  孙吉花
作者单位:碳青霉烯类耐药与敏感鲍曼不动杆菌医院感染经济损失的差异
基金项目:山东省医药卫生科技发展计划(2015WS0491,2017WS754)
摘    要:目的了解碳青霉烯类耐药与敏感鲍曼不动杆菌医院感染经济损失的差异,提高临床医务人员对耐碳青霉烯类鲍曼不动杆菌(CRAB)感染防控的认识。方法以某三甲医院2012年10月—2018年9月重症医学科(ICU)鲍曼不动杆菌感染患者为研究对象,依据其感染的鲍曼不动杆菌对碳青霉烯类敏感结果分为CRAB组和碳青霉烯类敏感鲍曼不动杆菌(CSAB)组,将两组患者按照配对标准1∶1配对,采用配对秩和检验分析两组患者的直接经济损失。结果最终匹配成功46对,CRAB组住院总费用中位数为179 192元,CSAB组为82 314元,两组差值为96 878元;CRAB组住院日数中位数为49 d,CSAB组为27 d,两组差值为22 d;两组患者住院总费用、住院日数比较,差异均有统计学意义(均P0.05)。CRAB医院感染患者直接经济损失的主要组成部分是西药费(29 246元)、材料费(19 465元)和治疗费(12 872元),占直接经济损失费用的63.6%。结论 CRAB医院感染导致患者住院日数延长,住院费用增加,因此降低CRAB医院感染发生率至关重要。

关 键 词:耐碳青霉烯类鲍曼不动杆菌  碳青霉烯类敏感鲍曼不动杆菌  医院感染  经济损失  
收稿时间:2019-08-20

Difference in economic loss between carbapenem-resistant Acinetobacter baumannii and carbapenem-susceptible Acinetobacter baumannii healthcare-associated infection
WANG Fang,SUN Qi-mei,LIU Xin,JIANG Xue-jin,SONG Shu-xi,SHAO Fang-fei,SONG Li-xi,SUN Ji-hua. Difference in economic loss between carbapenem-resistant Acinetobacter baumannii and carbapenem-susceptible Acinetobacter baumannii healthcare-associated infection[J]. Chinese Journal of Infection Control, 2019, 18(9): 842-847. DOI: 10.12138/j.issn.1671-9638.20195355
Authors:WANG Fang  SUN Qi-mei  LIU Xin  JIANG Xue-jin  SONG Shu-xi  SHAO Fang-fei  SONG Li-xi  SUN Ji-hua
Affiliation:1. Department of Neurology, Binzhou Medical University Hospital, Binzhou 256603, China;2. Department of Endocrinology, Binzhou Medical University Hospital, Binzhou 256603, China;3. Healthcare-associated Infection Management Office, Binzhou Medical University Hospital, Binzhou 256603, China;4. Neonatal Intensive Care Unit, Binzhou Medical University Hospital, Binzhou 256603, China
Abstract:Objective To understand the difference in economic loss between carbapenem-resistant Acinetobacter baumannii(CRAB) and carbapenem-susceptible Acinetobacter baumannii(CSAB) healthcare-associated infection(HAI), and improve health care workers' awareness on the prevention and control of CRAB infection. Methods Patients with Acinetobacter baumannii infection in the intensive acre unit(ICU) of a tertiary first-class hospital from October 2012 to September 2018 were studied and divided into CRAB group and CSAB group according to susceptibility of Acinetobacter baumannii to carbapenems, two groups were matched according to 1:1 matching standard, paired rank sum test was used to analyze the direct economic loss of two groups of patients. Results Forty-six pairs were matched, the median hospitalization expense of CRAB group and CSAB were 179 192 yuan and 82 314 yuan respectively, difference between two groups was 96 878 yuan; the median length of hospital stay of CRAB group and CSAB group were 49 days and 27 days respectively, difference between two groups was 22 days; difference in total hospitalization expense and length of hospital stay between two groups were both significant (both P<0.05). The main direct economic loss of patients with CRAB HAI were western medicine fee (29 246 yuan), material fee (19 465 yuan) and treatment fee (12 872 yuan), accounting for 63.6% of direct economic loss. Conclusion CRAB HAI can lead to prolonged length of hospital stay and increase hospitalization expense, so it is essential to reduce the incidence of CRAB HAI.
Keywords:carbapenem-resistant Acinetobacter baumannii  healthcare-associated infection  carbapenem-susceptible Acinetobacter baumannii  economic loss  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号